Skip to main content
SpringerLink
Log in

Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar

  • Letters of Biomedical and Clinical Research
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Zhao S, Chadwick L, Mysler E, Moots RJ (2018) Review of biosimilar trials and data on adalimumab in rheumatoid arthritis. Curr Rheumatol Rep 20(10):57. https://doi.org/10.1007/s11926-018-0769-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X (2020) Comparison of the efficacy and safety of adalimumab (Humira) and the adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis: a multicenter, randomized, double-blind, parallel, phase III clinical trial. BioDrugs 34(3):381–393. https://doi.org/10.1007/s40259-020-00408-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  Google Scholar 

  4. Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, Conner-spady B, Palsat J, Lambert RGW (2005) Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53(5):703–709. https://doi.org/10.1002/art.21445

    Article  PubMed  Google Scholar 

  5. Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ (2015) Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score. J Rheumatol 42(1):79–86. https://doi.org/10.3899/jrheum.140519

    Article  PubMed  Google Scholar 

  6. Zheng Y, Zhang K, Han Q, Hao Y, Liu Y, Yin H, Ding J, Zheng Z, Leng N, Jia J, Wu Z, Zhu P (2019) Application and preliminary validation of the hip inflammation MRI scoring system (HIMRISS) in spondyloarthritis. Int J Rheum Dis 22(2):228–233. https://doi.org/10.1111/1756-185X.13451

    Article  PubMed  Google Scholar 

  7. Huang ZG, Zhang XZ, Hong W, Wang GC, Zhou HQ, Lu X, Wang W (2013) The application of MR imaging in the detection of hip involvement in patients with ankylosing spondylitis. Eur J Radiol 82(9):1487–1493. https://doi.org/10.1016/j.ejrad.2013.03.020

    Article  PubMed  Google Scholar 

  8. Lambert RG, Salonen D, Rahman P et al (2007) Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 56(12):4005–4014. https://doi.org/10.1002/art.23044

    Article  CAS  PubMed  Google Scholar 

  9. Pedersen SJ, Weber U, Said-Nahal R, Sørensen IJ, Loft AG, Kollerup G, Juul L, Frandsen PB, Thamsborg G, Madsen OR, Møller J, Balding L, Jurik AG, Østergaard M (2018) Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor. Scand J Rheumatol 48(3):185–197. https://doi.org/10.1080/03009742.2018.1506822

    Article  CAS  PubMed  Google Scholar 

  10. Huang ZX, Deng WM, Guo X, Huang ZP, Huang YK, Lin CL, Li TW (2019) Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: an observational, retrospective cohort study. Clin Rheumatol 38(6):1595–1604. https://doi.org/10.1007/s10067-019-04466-9

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Zhejiang Hisun Pharmaceutical Inc. Co., Ltd.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, No 466 Xingangzhong Road, Guangzhou, 510317, China

    Zhi-Xiang Huang, Wei-Ming Deng, Shao-Ling Zheng, Xin Guo & Tian-Wang Li

  2. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China

    Zhi-Xiang Huang, Wei-Ming Deng, Shao-Ling Zheng, Xin Guo, Shao-Qing Zeng & Tian-Wang Li

  3. Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou, China

    Shao-Qing Zeng

Authors
  1. Zhi-Xiang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei-Ming Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shao-Ling Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shao-Qing Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tian-Wang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZH and TL provided the idea and performed the study design. WD and SZ collected the demographic and clinical information. ZH, SZ, and TL assessed the MRI pictures. ZH and XG performed the data analysis, interpretation, and prepared the original manuscript. TL critically reviewed the draft. All authors approved the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Tian-Wang Li.

Ethics declarations

This study was approved by the ethics committee of Guangdong Second Provincial General Hospital (2017-YXLLKS-001). Written informed consents in accordance with the declaration of Helsinki were given by participants.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral regarding jurisdictional claims in published maps and institutional affiliations.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, ZX., Deng, WM., Zheng, SL. et al. Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar. Clin Rheumatol 40, 2099–2101 (2021). https://doi.org/10.1007/s10067-021-05628-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05628-4

Search

Navigation